The store will not work correctly when cookies are disabled.
5-methoxy-4,6-dinitro-7H-dibenzo[de,h]quinolin-7-one
ID: ALA2332982
PubChem CID: 71719422
Max Phase: Preclinical
Molecular Formula: C17H9N3O6
Molecular Weight: 351.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1c([N+](=O)[O-])c2c3c(nccc3c1[N+](=O)[O-])-c1ccccc1C2=O
Standard InChI: InChI=1S/C17H9N3O6/c1-26-17-14(19(22)23)10-6-7-18-13-8-4-2-3-5-9(8)16(21)12(11(10)13)15(17)20(24)25/h2-7H,1H3
Standard InChI Key: FJWVMHXQYQHHQW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
11.5135 -6.7108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5124 -7.5304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2204 -7.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2187 -6.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9273 -6.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9307 -7.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6430 -7.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3561 -7.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0707 -7.9344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7830 -7.5189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7761 -6.6909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6363 -6.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3528 -6.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0668 -6.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0706 -5.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3540 -5.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6337 -5.4635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6455 -8.7570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4933 -7.9229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4985 -8.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0752 -8.7544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7848 -9.1597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3693 -9.1662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4805 -6.2708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4715 -5.4536 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1926 -6.6716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 12 1 0
6 7 1 0
7 8 1 0
13 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 14 2 0
12 13 1 0
12 17 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
7 18 2 0
10 19 1 0
19 20 1 0
21 22 2 0
21 23 1 0
9 21 1 0
24 25 2 0
24 26 1 0
11 24 1 0
M CHG 4 21 1 23 -1 24 1 26 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.27 | Molecular Weight (Monoisotopic): 351.0491 | AlogP: 3.27 | #Rotatable Bonds: 3 |
Polar Surface Area: 125.47 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.84 | CX LogP: 2.99 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.41 | Np Likeness Score: 0.24 |
References
1. Castro-Castillo V, Suárez-Rozas C, Castro-Loiza N, Theoduloz C, Cassels BK.. (2013) Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds., 62 [PMID:23454511] [10.1016/j.ejmech.2013.01.049] |